Health Equity Advocacy in Rare Disease: How Advocacy Groups Can Drive Systemic Change

Published: 05 Jun 2026

Health equity advocacy in rare disease means pushing beyond awareness toward structural change: inclusive trials, equitable funding, and policy that reflects community priorities.

Advocacy groups that connect with pharma and research partners through dedicated collaboration infrastructure can translate community voice into protocol influence, partnership design, and long-term research priorities.

Levers for systemic change

• Co-investigator and advisory roles in trial design
• Data and storytelling that centers underserved communities
• Coalition building across disease areas and sectors

Explore our platform · Join the network · Our health equity mission